Beacon (apple)
Beacon is a technology developed by Apple Inc., designed to enhance location-based services and functionalities in iOS devices. The technology uses Bluetooth Low Energy (BLE) proximity sensing to transmit a universally unique identifier that can be picked up by compatible devices and software. This identifier, along with other data, can be used to determine the device's physical location, track customers, or trigger location-based actions on the device.
History
The Beacon technology was first introduced by Apple Inc. at the Worldwide Developers Conference (WWDC) in 2013. It was initially incorporated into the iOS 7 operating system and has since been integrated into all subsequent versions of iOS.
Functionality
Beacon uses Bluetooth Low Energy (BLE) to broadcast signals that can be detected by compatible devices within its range. The technology can determine when a device is near or far from a Beacon, allowing for a range of location-based interactions.
For example, a Beacon can be used in a retail store to provide customers with product information when they are near a particular item. It can also be used in museums to provide visitors with information about exhibits as they move through the building.
Implementation
To implement Beacon, a developer must first register their iOS device with Apple's iBeacon service. Once registered, the device can start broadcasting its unique identifier to other devices within its range.
The Beacon technology is not limited to iOS devices. It can also be implemented on other platforms such as Android and Windows, provided they support BLE and can detect the Beacon's broadcast signals.
Criticisms and Controversies
Despite its potential, Beacon has faced criticism for its potential to invade privacy. Since the technology can track a device's location, it can potentially be used to monitor individuals without their consent. However, Apple has implemented measures to prevent this, such as requiring apps to request permission before accessing a device's location data.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD